array(1) { [0]=> object(Apache_Solr_Document)#24 (3) { ["_documentBoost":protected]=> bool(false) ["_fields":protected]=> array(6) { ["content_id"]=> array(1) { [0]=> string(14) "DIRECTORY_3529" } ["content_title"]=> array(1) { [0]=> string(17) "FABRIZIO BARBETTI" } ["description"]=> array(1) { [0]=> string(94368) "Inserire qui il curriculumInsert here the curriculum a:105:{i:0;a:14:{s:9:"citazione";s:200:"Sui, L., Xin, Y., Du, Q., Georgieva, D., Diedenhofen, G., Haataja, L., et al. (2021). Reduced replication fork speed promotes pancreatic endocrine differentiation and controls graft size. JCI INSIGHT.";s:4:"data";s:7:"2021-02";s:2:"id";s:20:"PUBBLICAZIONE_410242";s:6:"handle";s:11:"2108/265592";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/13";s:9:"metadata4";N;s:9:"metadata5";s:100:"Reduced replication fork speed promotes pancreatic endocrine differentiation and controls graft size";s:9:"metadata6";s:209:"Sui, L; Xin, Y; Du, Q; Georgieva, D; Diedenhofen, G; Haataja, L; Su, Q; Zuccaro, MV; Kim, J; Fu, J; Xing, Y; He, Y; Baum, D; Goland, RS; Wang, Y; Oberholzer, J; Barbetti, F; Arvan, P; Kleiner &, S; Egli, D";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:1;a:14:{s:9:"citazione";s:279:"Bowman, P., Mathews, F., Barbetti, F., Sheperd, M., Sanchez, J., Piccini, B., et al. (2021). Long-term follow-up of glycemic and neurological outcomes in an international series of patients with sulfonylurea-treated ABCC8 permanent neonatal diabetes. DIABETES CARE, 44(1), 35-42.";s:4:"data";s:7:"2021-01";s:2:"id";s:20:"PUBBLICAZIONE_398514";s:6:"handle";s:11:"2108/255066";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/13";s:9:"metadata4";N;s:9:"metadata5";s:156:"Long-term follow-up of glycemic and neurological outcomes in an international series of patients with sulfonylurea-treated ABCC8 permanent neonatal diabetes";s:9:"metadata6";s:217:"Bowman, P; Mathews, F; Barbetti, F; Sheperd, M; Sanchez, J; Piccini, B; Beltrand, J; Letourneau-Freiberg, L; Polak, M; Greeley, S; Rawlins, E; Babiker, T; Thomas, M; De Franco, E; Ellard, S; Flanagan, S; Hattersley, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:2;a:14:{s:9:"citazione";s:231:"Bonfanti, R., Iafusco, D., Rabbone, I., Diedenhofen, G., Bizzarri, C., Patera, P., et al. (2021). Differences between transient neonatal diabetes mellitus subtypes can guide diagnosis and therapy. EUROPEAN JOURNAL OF ENDOCRINOLOGY.";s:4:"data";s:4:"2021";s:2:"id";s:20:"PUBBLICAZIONE_431653";s:6:"handle";s:11:"2108/284869";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/13";s:9:"metadata4";N;s:9:"metadata5";s:97:"Differences between transient neonatal diabetes mellitus subtypes can guide diagnosis and therapy";s:9:"metadata6";s:509:"Bonfanti, R; Iafusco, D; Rabbone, I; Diedenhofen, G; Bizzarri, C; Patera, P; Reinstadler, P; Costantino, F; Calcaterra, V; Iughetti, L; Savastio, S; Favia, A; Cardella, F; LoPresti, D; Girtler, Y; Rabbiosi, S; D’Annunzio, G; Zanfardino, A; Piscopo, A; Casaburo, F; Pintomalli, L; Russo, L; Grasso, V; Minuto, N; Mucciolo, M; Novelli, A; Marucci, A; Piccini, B; Toni, S; Silvestri, F; Carrera, P; Rigamonti, A; Frontino, G; Trada, M; Tinti, D; Delvecchio, M; Rapini, N; Schiaffini, R; Mammì, C; Barbetti, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:3;a:14:{s:9:"citazione";s:288:"Iafusco, D., Zanfardino, A., Piscopo, A., Casaburo, F., De Nigris, A., Alfiero, S., et al. (2021). Case report: coeliac disease as a cause of secondary failure of glyburide therapy in a patient with permanent neonatal diabetes due to KCNJ11/R201C mutation. DIABETOLOGIA, 64(7), 1703-1706.";s:4:"data";s:4:"2021";s:2:"id";s:20:"PUBBLICAZIONE_431659";s:6:"handle";s:11:"2108/284877";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/13";s:9:"metadata4";N;s:9:"metadata5";s:156:"Case report: coeliac disease as a cause of secondary failure of glyburide therapy in a patient with permanent neonatal diabetes due to KCNJ11/R201C mutation";s:9:"metadata6";s:122:"Iafusco, D; Zanfardino, A; Piscopo, A; Casaburo, F; De Nigris, A; Alfiero, S; Russo, G; Arenella, M; Russo, M; Barbetti, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:4;a:14:{s:9:"citazione";s:210:"L, M., S, L., A, P., D, P., E, M., G, B., et al. (2020). Improved diagnosis of rare disease patients through systematic detection of runs of homozygosity. THE JOURNAL OF MOLECULAR DIAGNOSTICS, 22(9), 1205-1215.";s:4:"data";s:4:"2020";s:2:"id";s:20:"PUBBLICAZIONE_397664";s:6:"handle";s:11:"2108/258095";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/03";s:9:"metadata4";N;s:9:"metadata5";s:96:"Improved diagnosis of rare disease patients through systematic detection of runs of homozygosity";s:9:"metadata6";s:1019:"L, M; S, L; A, P; D, P; E, M; G, B; R, T; R, H; L, P; O, R; Ommen GJ, V; A, L; S, B; GPAP and URD-Cat data contributors Alessandra Renieri, R; Dursun, A; Matilla- Duenas, A; Cormand, B; Rivolta, C; Ayuso, C; Espinós, C; Scerri, C; Yalnizoglu, D; Soler, D; Morava, E; Barbetti, F; Forzano, F; Mari, F; Muntoni, F; Tort, F; James Houlden, H; Tejada, I; Senderek, J; Benitez, J; Corral De La Calle, J; Serra, J; Mª Millán, J; Segovia, J; Ramon Gimeno Blanes, J; Armstrong, J; Ozgul, K; Vilarinho, L; Montoliu, L; Posada, M; Antonietta Mencarelli, M; Mora, M; Bianchi, P; Seeman, P; Elliott, PM; Ferlini, A; Brice, A; Wirth, B; Muntoni, F; Hanna, M; Tabrizi, S; Klockgether, T; Timmerman, V; Straub, V; Hiz Kurul, S; Oktay, Y; Gungor, S; Yaramis, A; Yis, U; Macaya, A; Ribes, A; Pujol, A; Lázaro, C; Grinberg, D; Tizzano, E; Cardellach, F; Palau, F; Milà, M; Gallano, P; Artuch, R; Martí Seves, R; Villanueva, G; Vidal, S; Garrabou, G; Balcells, S; Urreizti, R; López, E; Cuscó, I; Valenzuela, I; Sabater., M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:5;a:14:{s:9:"citazione";s:272:"Schiaffini, R., Barbetti, F., Rapini, N., Inzaghi, E., Deodati, A., Patera, I., et al. (2020). School and preschool children with type 1 diabetes during COVID-19 quarantine: the synergic effect of parental care and technology. DIABETES RESEARCH AND CLINICAL PRACTICE, 166.";s:4:"data";s:4:"2020";s:2:"id";s:20:"PUBBLICAZIONE_397659";s:6:"handle";s:11:"2108/254314";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/13";s:9:"metadata4";N;s:9:"metadata5";s:130:"School and preschool children with type 1 diabetes during COVID-19 quarantine: the synergic effect of parental care and technology";s:9:"metadata6";s:156:"Schiaffini, R; Barbetti, F; Rapini, N; Inzaghi, E; Deodati, A; Patera, I; Matteoli, M; Ciampalini, P; Carducci, C; Lorubbio, A; Schiaffini, G; Cianfarani, S";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:6;a:14:{s:9:"citazione";s:142:"Barbetti, F., & Taylor, S.I. (2019). Insulin: Still a miracle after all these years. THE JOURNAL OF CLINICAL INVESTIGATION, 129(8), 3045-3047.";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_367418";s:6:"handle";s:11:"2108/237043";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:46:"Insulin: Still a miracle after all these years";s:9:"metadata6";s:23:"Barbetti, F; Taylor, SI";s:9:"metadata7";s:17:"10.1172/JCI130310";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:7;a:14:{s:9:"citazione";s:157:"Maghnie, M., & Barbetti, F. (2019). MEHMO syndrome and the link between brain, pituitary and pancreas. EBIOMEDICINE, 42, 26-27 [10.1016/j.ebiom.2019.03.086].";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_367417";s:6:"handle";s:11:"2108/237038";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:65:"MEHMO syndrome and the link between brain, pituitary and pancreas";s:9:"metadata6";s:23:"Maghnie, M; Barbetti, F";s:9:"metadata7";s:27:"10.1016/j.ebiom.2019.03.086";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:8;a:14:{s:9:"citazione";s:265:"Mascolo, E., Barile, A., Mecarelli, L.S., Amoroso, N., Merigliano, C., Massimi, A., et al. (2019). The expression of four pyridoxal kinase (PDXK) human variants in Drosophila impacts on genome integrity. SCIENTIFIC REPORTS, 9(1), 14188 [10.1038/s41598-019-50673-4].";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_367419";s:6:"handle";s:11:"2108/237046";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:103:"The expression of four pyridoxal kinase (PDXK) human variants in Drosophila impacts on genome integrity";s:9:"metadata6";s:164:"Mascolo, E; Barile, A; Mecarelli, LS; Amoroso, N; Merigliano, C; Massimi, A; Saggio, I; Hansen, T; Tramonti, A; Di Salvo, ML; Barbetti, F; Contestabile, R; Verni, F";s:9:"metadata7";s:26:"10.1038/s41598-019-50673-4";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:9;a:14:{s:9:"citazione";s:225:"Ma, S., Viola, R., Sui, L., Cherubini, V., Barbetti, F., & Egli, D. (2018). b Cell Replacement after Gene Editing of a Neonatal Diabetes-Causing Mutation at the Insulin Locus. STEM CELL REPORTS [10.1016/j.stemcr.2018.11.006].";s:4:"data";s:10:"2018-11-06";s:2:"id";s:20:"PUBBLICAZIONE_343291";s:6:"handle";s:11:"2108/208512";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:98:"b Cell Replacement after Gene Editing of a Neonatal Diabetes-Causing Mutation at the Insulin Locus";s:9:"metadata6";s:59:"Ma, S; Viola, R; Sui, L; Cherubini, V; Barbetti, F; Egli, D";s:9:"metadata7";s:28:"10.1016/j.stemcr.2018.11.006";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:10;a:14:{s:9:"citazione";s:280:"Delvecchio, M., Salzano, G., Bonura, C., Cauvin, V., Cherubini, V., D’Annunzio, G., et al. (2018). Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?. ACTA DIABETOLOGICA, 55(9), 981-983 [10.1007/s00592-018-1179-y].";s:4:"data";s:7:"2018-09";s:2:"id";s:20:"PUBBLICAZIONE_343490";s:6:"handle";s:11:"2108/208583";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:114:"Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?";s:9:"metadata6";s:330:"Delvecchio, M; Salzano, G; Bonura, C; Cauvin, V; Cherubini, V; D’Annunzio, G; Franzese, A; Giglio, S; Grasso, V; Graziani, V; Iafusco, D; Iughetti, L; Lera, R; Maffeis, C; Maltoni, G; Mantovani, V; Menzaghi, C; Oater, P; Rabbone, I; Reinstadler, P; Scelfo, S; Tinto, N; Toni, S; Tumini, S; Lombardo, F; Nicolucci, A; Barbetti, F";s:9:"metadata7";s:25:"10.1007/s00592-018-1179-y";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:11;a:14:{s:9:"citazione";s:209:"Barbetti, F., & D'Annunzio, G. (2018). Genetic causes and treatment of neonatal diabetes and early childhood diabetes. BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL ENDOCRINOLOGY & METABOLISM, 32(4), 575-591.";s:4:"data";s:10:"2018-06-25";s:2:"id";s:20:"PUBBLICAZIONE_343417";s:6:"handle";s:11:"2108/208516";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:78:"Genetic causes and treatment of neonatal diabetes and early childhood diabetes";s:9:"metadata6";s:26:"Barbetti, F; D'Annunzio, G";s:9:"metadata7";s:26:"10.1016/j.beem.2018.06.008";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:12;a:14:{s:9:"citazione";s:332:"Bowman, P., Sulen, A., Barbetti, F., Beltrand, J., Svalastoga, P., Codner, E., et al. (2018). Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study. THE LANCET DIABETES & ENDOCRINOLOGY, 6, 637-646 [10.1016/S2213-8587(18)30106-2].";s:4:"data";s:10:"2018-06-04";s:2:"id";s:20:"PUBBLICAZIONE_343290";s:6:"handle";s:11:"2108/208514";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:157:"Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.";s:9:"metadata6";s:310:"Bowman, P; Sulen, A; Barbetti, F; Beltrand, J; Svalastoga, P; Codner, E; Tessmann Ellen, H; Juliusson Petur, B; Skrivarhaug, T; Pearson Ewan, R; Flanagan Sarah, E; Babiker, T; Thomas Nicholas, J; Shepherd Maggie, H; Ellard, S; Klimes, I; Szopa, M; Polak, M; Iafusco, D; Hattersley Andrew, T; Njølstad Pål, R";s:9:"metadata7";s:29:"10.1016/S2213-8587(18)30106-2";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:13;a:14:{s:9:"citazione";s:261:"Innaurato, S., Brierley, G., Grasso, V., Massimi, A., Gaudino, R., Sileno, S., et al. (2018). Severe insulin resistance in disguise: a familiar case of reactive hypoglycemia associated with a novel heterozygous INSR mutation. PEDIATRIC DIABETES, 19(4), 670-674.";s:4:"data";s:10:"2018-02-07";s:2:"id";s:20:"PUBBLICAZIONE_343419";s:6:"handle";s:11:"2108/208518";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:130:"Severe insulin resistance in disguise: a familiar case of reactive hypoglycemia associated with a novel heterozygous INSR mutation";s:9:"metadata6";s:110:"Innaurato, S; Brierley, G; Grasso, V; Massimi, A; Gaudino, R; Sileno, S; Bernardini, S; Semple, R; Barbetti, F";s:9:"metadata7";s:18:"10.1111/pedi.12632";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:14;a:14:{s:9:"citazione";s:307:"Barbetti, F., Mammì, C., Liu, M., Grasso, V., Arvan, P., Remedi, M., et al. (2017). Neonatal Diabetes: permanent neonatal diabetes and transient neonatal diabetes. In L.G. F. Barbetti (a cura di), Diabetes associated with single gene defects and chromosomal abnormalities. S Karger AG, Basel, Switzerland.";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_378537";s:6:"handle";s:11:"2108/237665";s:9:"metadata1";s:19:"Contributo in libro";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/13";s:9:"metadata4";N;s:9:"metadata5";s:78:"Neonatal Diabetes: permanent neonatal diabetes and transient neonatal diabetes";s:9:"metadata6";s:75:"Barbetti, F; Mammì, C; Liu, M; Grasso, V; Arvan, P; Remedi, M; Nichols, C";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:15;a:14:{s:9:"citazione";s:283:"Delvecchio, M., Mozzillo, E., Salzano, G., Iafusco, D., Frontino, G., Patera, P., et al. (2017). Monogenic Diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes Centers during 2007-2012. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 102(6), 1826-1834.";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_302624";s:6:"handle";s:11:"2108/173261";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:32:"Settore MED/03 - Genetica Medica";s:9:"metadata4";N;s:9:"metadata5";s:112:"Monogenic Diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes Centers during 2007-2012";s:9:"metadata6";s:284:"Delvecchio, M; Mozzillo, E; Salzano, G; Iafusco, D; Frontino, G; Patera, P; Rabbone, I; Cherubini, V; Grasso, V; Tinto, N; Giglio, S; Contreas, G; Di Paola, R; Salina, A; Cauvin, V; Tumini, S; d’Annunzio, G; Iughetti, L; Mantovani, V; Maltoni, G; Toni, S; Marigliano, M; Barbetti, F";s:9:"metadata7";s:20:"10.1210/jc.2016-2490";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:16;a:14:{s:9:"citazione";s:187:"Barbetti, F., Buzzetti, R., Cerutti, F., Copetti, M., Dauriz, M., Penno, G., et al. (2016). Consulenza genetica e diabete. In Il diabete in Italia (pp. 135-142). Bononia University Press.";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_378584";s:6:"handle";s:11:"2108/237711";s:9:"metadata1";s:19:"Contributo in libro";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/03";s:9:"metadata4";N;s:9:"metadata5";s:29:"Consulenza genetica e diabete";s:9:"metadata6";s:84:"Barbetti, F; Buzzetti, R; Cerutti, F; Copetti, M; Dauriz, M; Penno, G; Trischitta, V";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:17;a:14:{s:9:"citazione";s:241:"Barbetti, F., Colombo, C., Hataaja, L., Bernardini, S., & Arvan, P. (2016). Hyperglucagonemia in an animal model of insulin-deficient diabetes: what therapies can improve it ?. CLINICAL DIABETES AND ENDOCRINOLOGY [10.1186/s40842-016-0029-5].";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_302618";s:6:"handle";s:11:"2108/173257";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:99:"Hyperglucagonemia in an animal model of insulin-deficient diabetes: what therapies can improve it ?";s:9:"metadata6";s:60:"Barbetti, F; Colombo, C; Hataaja, L; Bernardini, S; Arvan, P";s:9:"metadata7";s:25:"10.1186/s40842-016-0029-5";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:18;a:14:{s:9:"citazione";s:239:"Costantini, S., Contreas, G., Barbetti, F., & Maffeis, C. (2016). Quando l’iperglicemia non è diabete di tipo 1 né di tipo 2: il MODY nella pratica clinica. G Ital Diabetol Metab. GIDM. GIORNALE ITALIANO DI DIABETOLOGIA E METABOLISMO.";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_378604";s:6:"handle";s:11:"2108/237730";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/13";s:9:"metadata4";N;s:9:"metadata5";s:117:"Quando l’iperglicemia non è diabete di tipo 1 né di tipo 2: il MODY nella pratica clinica. G Ital Diabetol Metab";s:9:"metadata6";s:51:"Costantini, S; Contreas, G; Barbetti, F; Maffeis, C";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:19;a:14:{s:9:"citazione";s:241:"Fintini, D., Cappa, M., Brufani, C., Bernardini, S., & Barbetti, F. (2016). Prevalence of elevated 1-h plasma glucose and its associations in obese youth. DIABETES RESEARCH AND CLINICAL PRACTICE, 116, 202-204 [10.1016/j.diabres.2016.04.045].";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_302622";s:6:"handle";s:11:"2108/173259";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:78:"Prevalence of elevated 1-h plasma glucose and its associations in obese youth.";s:9:"metadata6";s:60:"Fintini, D; Cappa, M; Brufani, C; Bernardini, S; Barbetti, F";s:9:"metadata7";s:29:"10.1016/j.diabres.2016.04.045";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:20;a:14:{s:9:"citazione";s:258:"Iafusco, D., Confetto, S., Zanfardino, A., Piscopo, A., Casaburo, F., Cocca, A., et al. (2016). Non autoimmune diabetes mellitus in pediatrics. In Research into childhood-onset diabetes. From study design to improved management (pp. 137-146). Springer eBook.";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_378591";s:6:"handle";s:11:"2108/237718";s:9:"metadata1";s:19:"Contributo in libro";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/13";s:9:"metadata4";N;s:9:"metadata5";s:46:"Non autoimmune diabetes mellitus in pediatrics";s:9:"metadata6";s:155:"Iafusco, D; Confetto, S; Zanfardino, A; Piscopo, A; Casaburo, F; Cocca, A; Caredda, E; Pezzino, G; Tinto, N; Pirozzi, D; Napoli, A; Barbetti, F; Perrone, L";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:21;a:14:{s:9:"citazione";s:249:"Ortolani, F., Piccinno, E., Grasso, V., Papadia, F., Panzeca, R., Cortese, C., et al. (2016). Diabetes associated with dominant insulin gene mutations: outcome of 24-month, sensor-augmented insulin pump treatment. ACTA DIABETOLOGICA, 53(3), 499-501.";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_302611";s:6:"handle";s:11:"2108/173250";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:118:"Diabetes associated with dominant insulin gene mutations: outcome of 24-month, sensor-augmented insulin pump treatment";s:9:"metadata6";s:111:"Ortolani, F; Piccinno, E; Grasso, V; Papadia, F; Panzeca, R; Cortese, C; Tummolo, A; Vendemiale, M; Barbetti, F";s:9:"metadata7";s:25:"10.1007/s00592-015-0793-1";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:22;a:14:{s:9:"citazione";s:312:"Rabbone, I., Barbetti, F., Marigliano, M., Bonfanti, R., Piccinno, E., Ortoloani, F., et al. (2016). Successful treatment of young infants presenting Neonatal Diabetes Mellitus with continuous subcutaneous insulin infusion before genetic diagnosis. ACTA DIABETOLOGICA, 53(4), 559-565 [10.1007/s00592-015-0828-7].";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_302616";s:6:"handle";s:11:"2108/173254";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:147:"Successful treatment of young infants presenting Neonatal Diabetes Mellitus with continuous subcutaneous insulin infusion before genetic diagnosis.";s:9:"metadata6";s:156:"Rabbone, I; Barbetti, F; Marigliano, M; Bonfanti, R; Piccinno, E; Ortoloani, F; Ignaccolo, G; Maffeis, C; Confetto, S; Cerutti, F; Zanfardino, A; Iafusco, D";s:9:"metadata7";s:25:"10.1007/s00592-015-0828-7";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:23;a:14:{s:9:"citazione";s:112:"Barbetti, F. (2015). Il MODY. Guida pratica alla diagnosi clinica e alla identificazione molecolare. IL DIABETE.";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_378601";s:6:"handle";s:11:"2108/237728";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/13";s:9:"metadata4";N;s:9:"metadata5";s:78:"Il MODY. Guida pratica alla diagnosi clinica e alla identificazione molecolare";s:9:"metadata6";s:11:"Barbetti, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:24;a:14:{s:9:"citazione";s:192:"Iafusco, D., Barbetti, F., Massimi, A., Grasso, V., Rabbone, I., Casaburo, F., et al. (2015). Diabete tipo 1, tipo 2 e tipo X. Ipeglicemia in età pediatrica: quale diabete ?. AREA PEDIATRICA.";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_378594";s:6:"handle";s:11:"2108/237722";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/13";s:9:"metadata4";N;s:9:"metadata5";s:80:"Diabete tipo 1, tipo 2 e tipo X. Ipeglicemia in età pediatrica: quale diabete ?";s:9:"metadata6";s:287:"Iafusco, D; Barbetti, F; Massimi, A; Grasso, V; Rabbone, I; Casaburo, F; Cocca, A; Confetto, S; Galderisi, A; Paccone, A; Picariello, S; Piscopo, A; Russo, L; Villano, P; Zanfardino, A; Prisco, F; Tinto, N; Mazzaccara, C; Pirozzi, D; De Sanctis, P; Pinelli, M; Acquaviva, F; Sacchetti, L";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:25;a:14:{s:9:"citazione";s:221:"Liu, M., Sun, J., Cui, J., Chen, W., Guo, H., BARBETTI, F., et al. (2015). INS-gene mutations: from genetics and beta cell biology and clinical disease. MOLECULAR ASPECTS OF MEDICINE, 42, 3-18 [10.1016/j.mam.2014.12.001].";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_302296";s:6:"handle";s:11:"2108/173012";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:76:"INS-gene mutations: from genetics and beta cell biology and clinical disease";s:9:"metadata6";s:62:"Liu, M; Sun, J; Cui, J; Chen, W; Guo, H; BARBETTI, F; Arvan, P";s:9:"metadata7";s:25:"10.1016/j.mam.2014.12.001";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:26;a:14:{s:9:"citazione";s:270:"Maiorana, A., Manganozzi, L., BARBETTI, F., Bernabei, S., Gallo, G., Cusmai, R., et al. (2015). Ketogenic diet in a patient with congenital hyperinsulinism: a novel approach to prevent brain damage. ORPHANET JOURNAL OF RARE DISEASES, 10, 120 [10.1186/s13023-015-0342-6].";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_302592";s:6:"handle";s:11:"2108/173240";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:51:"Settore MED/38 - Pediatria Generale e Specialistica";s:9:"metadata4";N;s:9:"metadata5";s:101:"Ketogenic diet in a patient with congenital hyperinsulinism: a novel approach to prevent brain damage";s:9:"metadata6";s:103:"Maiorana, A; Manganozzi, L; BARBETTI, F; Bernabei, S; Gallo, G; Cusmai, R; Caviglia, S; Dionisi Vici, C";s:9:"metadata7";s:25:"10.1186/s13023-015-0342-6";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:27;a:14:{s:9:"citazione";s:318:"Mozzillo, E., Salzano, G., Barbetti, F., Maffeis, C., Lombardo, F., Franzese, A., et al. (2015). Survey on etiological diagnosis of diabetes in 1244 Italian diabetic children and adolescents: Impact of access to genetic testing. DIABETES RESEARCH AND CLINICAL PRACTICE, 107(3), e15-e18 [10.1016/j.diabres.2015.01.003].";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_377967";s:6:"handle";s:11:"2108/237633";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/13";s:9:"metadata4";N;s:9:"metadata5";s:130:"Survey on etiological diagnosis of diabetes in 1244 Italian diabetic children and adolescents: Impact of access to genetic testing";s:9:"metadata6";s:104:"Mozzillo, E; Salzano, G; Barbetti, F; Maffeis, C; Lombardo, F; Franzese, A; Delvecchio, M; Marigliano, M";s:9:"metadata7";s:29:"10.1016/j.diabres.2015.01.003";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:28;a:14:{s:9:"citazione";s:258:"Prudente, S., Jungtrakoon, P., Marucci, A., Ludovico, O., Buranasupkajorn, P., Mazza, T., et al. (2015). Loss-of-function mutations in the APPL1 gene in familial diabetes mellitus. AMERICAN JOURNAL OF HUMAN GENETICS, 97, 177-185 [10.1016/j.ajhg.2015.05.011].";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_302294";s:6:"handle";s:11:"2108/173010";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:75:"Loss-of-function mutations in the APPL1 gene in familial diabetes mellitus.";s:9:"metadata6";s:309:"Prudente, S; Jungtrakoon, P; Marucci, A; Ludovico, O; Buranasupkajorn, P; Mazza, T; Hastings, T; Milano, T; Morini, E; Mercuri, L; Bailetti, D; Mendonca, C; Alberico, F; Basile, G; Romani, M; Miccinilli, E; Pizzuti, A; Carella, M; BARBETTI, F; Pascarella, S; Marchetti, P; Trischitta, V; Di Paola, R; Doria, A";s:9:"metadata7";s:26:"10.1016/j.ajhg.2015.05.011";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:29;a:14:{s:9:"citazione";s:196:"Rabbone, I., Galderisi, A., Tinti, D., Ignaccolo, M., BARBETTI, F., & Cerutti, F. (2015). When an induced illness looks like a rare disease. PEDIATRICS, 136(5), 1361-1365 [10.1542/peds.2014-4165].";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_302602";s:6:"handle";s:11:"2108/173246";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:51:"Settore MED/38 - Pediatria Generale e Specialistica";s:9:"metadata4";N;s:9:"metadata5";s:50:"When an induced illness looks like a rare disease.";s:9:"metadata6";s:73:"Rabbone, I; Galderisi, A; Tinti, D; Ignaccolo, M; BARBETTI, F; Cerutti, F";s:9:"metadata7";s:22:"10.1542/peds.2014-4165";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:30;a:14:{s:9:"citazione";s:263:"Maiorana, A., BARBETTI, F., Boiani, A., Rufini, V., Pizzoferro, M., Francalanci, P., et al. (2014). Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening. CLINICAL ENDOCRINOLOGY, 81(5), 679-688.";s:4:"data";s:7:"2014-11";s:2:"id";s:20:"PUBBLICAZIONE_198606";s:6:"handle";s:10:"2108/95226";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/03";s:9:"metadata4";N;s:9:"metadata5";s:122:"Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening";s:9:"metadata6";s:186:"Maiorana, A; BARBETTI, F; Boiani, A; Rufini, V; Pizzoferro, M; Francalanci, P; Faletra, F; Colin, G; Nichols, C; Grimaldi, C; DE VILLE DE GOYET, J; Rahier, J; Henquin, J; Dionisi Vici, C";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:31;a:14:{s:9:"citazione";s:243:"Iafusco, D., Salardi, S., Chiari, G., Toni, S., Rabbone, I., Pesavento, R., et al. (2014). No sign of proliferatve retinopathy in 15 patients with Permanent Neonatal Diabetes Mellitus with a median diabetes duration of 24 years. DIABETES CARE.";s:4:"data";s:7:"2014-08";s:2:"id";s:20:"PUBBLICAZIONE_198609";s:6:"handle";s:10:"2108/95237";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:136:"No sign of proliferatve retinopathy in 15 patients with Permanent Neonatal Diabetes Mellitus with a median diabetes duration of 24 years";s:9:"metadata6";s:189:"Iafusco, D; Salardi, S; Chiari, G; Toni, S; Rabbone, I; Pesavento, R; Pasquino, B; de Benedictis, A; Maltoni, G; Colombo, C; Russo, L; Massa, O; Sudano, M; Cadario, F; Porta, M; Barbetti, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:32;a:14:{s:9:"citazione";s:216:"Sileno, S., D’Oria, V., Stucchi, R., Alessio, M., Petrini, S., Bonetto, V., et al. (2014). A possible role of transglutaminase 2 in the nucleus of INS-1E and cells of human pancreatic islets. JOURNAL OF PROTEOMICS.";s:4:"data";s:10:"2014-01-16";s:2:"id";s:20:"PUBBLICAZIONE_198554";s:6:"handle";s:10:"2108/95191";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:100:"A possible role of transglutaminase 2 in the nucleus of INS-1E and cells of human pancreatic islets.";s:9:"metadata6";s:143:"Sileno, S; D’Oria, V; Stucchi, R; Alessio, M; Petrini, S; Bonetto, V; Maechler, P; Bertuzzi, F; Grasso, V; Paolella, K; Barbetti, F; Massa, O";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:33;a:14:{s:9:"citazione";s:303:"Delvecchio, M., Ludovico, O., Menzaghi, C., Di Paola, R., Zelante, L., Marucci, A., et al. (2014). Low prevalence of HNF1A mutations after molecular screening of multiple MODY genes in 58 Italian families recruited in the pediatric or adult diabetes clinic from a single Italian hospital. DIABETES CARE.";s:4:"data";s:4:"2014";s:2:"id";s:20:"PUBBLICAZIONE_198610";s:6:"handle";s:10:"2108/95349";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:188:"Low prevalence of HNF1A mutations after molecular screening of multiple MODY genes in 58 Italian families recruited in the pediatric or adult diabetes clinic from a single Italian hospital";s:9:"metadata6";s:127:"Delvecchio, M; Ludovico, O; Menzaghi, C; Di Paola, R; Zelante, L; Marucci, A; Grasso, V; Trischitta, V; Carella, M; Barbetti, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:34;a:14:{s:9:"citazione";s:265:"Grasso, V., Colombo, C., Favalli, V., Galderisi, A., Rabbone, I., Gombos, S., et al. (2013). Six cases with severe insulin resistance (SIR) associated with mutations of insulin receptor. Is it a Barterr-like syndrome a feature of congenital SIR. ACTA DIABETOLOGICA.";s:4:"data";s:7:"2013-12";s:2:"id";s:20:"PUBBLICAZIONE_198543";s:6:"handle";s:10:"2108/95189";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:152:"Six cases with severe insulin resistance (SIR) associated with mutations of insulin receptor. Is it a Barterr-like syndrome a feature of congenital SIR.";s:9:"metadata6";s:156:"Grasso, V; Colombo, C; Favalli, V; Galderisi, A; Rabbone, I; Gombos, S; Bonora, E; Meschi, F; Cerutti, F; Iafusco, D; Bonfanti, R; Monciotti, C; Barbetti, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:35;a:14:{s:9:"citazione";s:256:"Pinelli, M., Acquaviva, F., Barbetti, F., Caredda, E., Cocozza, S., Delvecchio, M., et al. (2013). Identification of candidate children for maturity-onset diabetes of the young type 2 (MODY2) gene testing: a seven-item clinical flow-chart (7-iF). PLOS ONE.";s:4:"data";s:10:"2013-11-11";s:2:"id";s:20:"PUBBLICAZIONE_198549";s:6:"handle";s:10:"2108/95190";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:146:"Identification of candidate children for maturity-onset diabetes of the young type 2 (MODY2) gene testing: a seven-item clinical flow-chart (7-iF)";s:9:"metadata6";s:182:"Pinelli, M; Acquaviva, F; Barbetti, F; Caredda, E; Cocozza, S; Delvecchio, M; Mozzillo, E; Pirozzi, D; Prisco, F; Rabbone, I; Sacchetti, L; Tinto, N; Toni, S; Zucchini, S; Iafusco, D";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:36;a:14:{s:9:"citazione";s:235:"Deodati, A., Inzaghi, E., Liguori, A., Puglianiello, A., Germani, D., Brufani, C., et al. (2013). IGF2 methylation is associated with lipid profile in obese children. HORMONE RESEARCH IN PAEDIATRICS, 79(6), 361-367 [10.1159/000351707].";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_209539";s:6:"handle";s:10:"2108/99599";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:51:"Settore MED/38 - Pediatria Generale e Specialistica";s:9:"metadata4";N;s:9:"metadata5";s:67:"IGF2 methylation is associated with lipid profile in obese children";s:9:"metadata6";s:125:"Deodati, A; Inzaghi, E; Liguori, A; Puglianiello, A; Germani, D; Brufani, C; Fintini, D; Cappa, M; Barbetti, F; Cianfarani, S";s:9:"metadata7";s:17:"10.1159/000351707";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:37;a:14:{s:9:"citazione";s:357:"Lin, Y., Li, A., Grasso, V., Battaglia, D., Crinò, A., Colombo, C., et al. (2013). Functional characterization of a novel KCNJ11 in frame mutation-deletion associated with early onset diabetes and a mild form of intermediate DEND: a battle between KATP gain of channel activity and loss of channel expression. PLOS ONE, 8(5) [10.1371/journal.pone.0063758].";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_164568";s:6:"handle";s:10:"2108/79810";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:226:"Functional characterization of a novel KCNJ11 in frame mutation-deletion associated with early onset diabetes and a mild form of intermediate DEND: a battle between KATP gain of channel activity and loss of channel expression.";s:9:"metadata6";s:89:"Lin, Y-W; Li, A; Grasso ,V; Battaglia, D; Crinò, A; Colombo, C; Barbetti, F; Nichols, CG";s:9:"metadata7";s:28:"10.1371/journal.pone.0063758";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:38;a:14:{s:9:"citazione";s:274:"Massa, O., Alessio, M., Russo, L., Nardo, G., Bonetto, V., Bertuzzi, F., et al. (2013). Serological proteome analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes. JOURNAL OF PROTEOMICS, 82, 263-273 [10.1016/j.jprot.2013.02.030].";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_164566";s:6:"handle";s:10:"2108/79807";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore BIO/12";s:9:"metadata4";N;s:9:"metadata5";s:119:"Serological proteome analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes";s:9:"metadata6";s:160:"Massa, O; Alessio, M; Russo, L; Nardo, G; Bonetto, V; Bertuzzi, F; Paladini, A; Iafusco, D; Patera, P; Federici, G; Not, T; Tiberti, C; Bonfanti, R; Barbetti, F";s:9:"metadata7";s:27:"10.1016/j.jprot.2013.02.030";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:39;a:14:{s:9:"citazione";s:300:"Battaglia, D., Lin, Y., Brogna, C., Crinò, A., Grasso, V., Mozzi, A.F., et al. (2012). Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225T, del226-232 mutation. PEDIATRIC DIABETES, 13, 656-660 [10.1111/j.1399-5448.2012.00874.x].";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_164564";s:6:"handle";s:10:"2108/77711";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:143:"Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225T, del226-232 mutation";s:9:"metadata6";s:148:"Battaglia, D; Lin, Y-W; Brogna, C; Crinò, A; Grasso, V; Mozzi, AF; Russo, L; Spera, S; Colombo, C; Ricci, S; Nichols, CG; Mercuri, E; Barbetti, F";s:9:"metadata7";s:32:"10.1111/j.1399-5448.2012.00874.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:40;a:14:{s:9:"citazione";s:130:"Iafusco D, M.O. (2012). Minimal Incidence of Neonatal/Infancy Onset Diabetes in Italy is 1:90,000 live births. ACTA DIABETOLOGICA.";s:4:"data";s:4:"2012";s:2:"id";s:19:"PUBBLICAZIONE_71685";s:6:"handle";s:10:"2108/55348";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:85:"Minimal Incidence of Neonatal/Infancy Onset Diabetes in Italy is 1:90,000 live births";s:9:"metadata6";s:193:"Iafusco D, Massa O, Pasquino B, Colombo C, Iughetti L, Bizzarri C, Mammì C, Nichols CG, Lo Presti D, Suprani T, Schiaffini R, Russo L, Grasso V, Meschi F, Bonfanti R, Brescianini S, Barbetti F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:41;a:14:{s:9:"citazione";s:118:"Liu M, L.R. (2012). Impaired cleavage of preproinsulin signal peptide linked to autosomal-dominant diabetes. DIABETES.";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_103934";s:6:"handle";s:10:"2108/55345";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:87:"Impaired cleavage of preproinsulin signal peptide linked to autosomal-dominant diabetes";s:9:"metadata6";s:88:"Liu M, Lara-Lemus R, Shan SO, Wright J, Haataja L, Barbetti F, Guo H, Larkin D, Arvan P.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:42;a:14:{s:9:"citazione";s:127:"Brufani C, F.D. (2011). Prediabetes in Italian children and youngsters. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 34, 275-280.";s:4:"data";s:4:"2011";s:2:"id";s:20:"PUBBLICAZIONE_104052";s:6:"handle";s:10:"2108/55350";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:47:"Prediabetes in Italian children and youngsters.";s:9:"metadata6";s:111:"Brufani C, Fintini D, Ciampalini P, Nocerino V, Crea F, Giannone G, Patera PI, Valerio G, Cappa M, Barbetti F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:43;a:14:{s:9:"citazione";s:256:"Colombo, C., Geraci, C., Suprani, T., Pocecco, M., & Barbetti F (2011). Macrosomia, transient neonatal hypoglycemia and monogenic diabetes in a family with heterozygous mutation R154X of HNF4A gene. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 34, 252-253.";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_32515";s:6:"handle";s:10:"2108/55342";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:127:"Macrosomia, transient neonatal hypoglycemia and monogenic diabetes in a family with heterozygous mutation R154X of HNF4A gene.";s:9:"metadata6";s:57:"Colombo, C; Geraci, C; Suprani, T; Pocecco, M; Barbetti F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:44;a:14:{s:9:"citazione";s:202:"Iafusco D, B.C. (2011). No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes. DIABETOLOGIA, 54(10), 2736-2738.";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_71684";s:6:"handle";s:10:"2108/55343";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:144:"No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes";s:9:"metadata6";s:110:"Iafusco D, Bizzarri C, Cadario F, Pesavento R, Tonini G, Tumini S, Cauvin V, Colombo C, Bonfanti R, Barbetti F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:45;a:14:{s:9:"citazione";s:328:"Loechner, K.J., Akrouh, A., Kurata, H.T., Dionisi-Vici, C., Maiorana, A., Pizzoferro, M., et al. (2011). Congenital hyperinsulinism and glucose hypersensitivity in homozygous and heterozygous carriers of Kir6.2 (KCNJ11) mutation V290M mutation. KATP channel inactivation mechanism and clinical management. DIABETES, 60, 209-217.";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_32526";s:6:"handle";s:10:"2108/55344";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:200:"Congenital hyperinsulinism and glucose hypersensitivity in homozygous and heterozygous carriers of Kir6.2 (KCNJ11) mutation V290M mutation. KATP channel inactivation mechanism and clinical management.";s:9:"metadata6";s:164:"Loechner, KJ; Akrouh, A; Kurata, HT; Dionisi-Vici, C; Maiorana, A; Pizzoferro, M; Rufini, V; de Ville de Goyet, J; Colombo, C; Barbetti, F; Koster, JC; Nichols, CG.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:46;a:14:{s:9:"citazione";s:243:"Russo, L., Iafusco, D., Brescianini, S., Nocerino, V., Bizzarri, C., Toni, S., et al. (2011). Permanent diabetes during the first year of life: multiple gene screening in 54 patients. DIABETOLOGIA, 54(7), 1693-1701 [10.1007/s00125-011-2094-8].";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_32500";s:6:"handle";s:10:"2108/55341";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:88:"Permanent diabetes during the first year of life: multiple gene screening in 54 patients";s:9:"metadata6";s:243:"Russo, L; Iafusco, D; Brescianini, S; Nocerino, V; Bizzarri, C; Toni, S; Cerutti, F; Monciotti, C; Pesavento, R; Iughetti, L; Bernardini, L; Bonfanti, R; Gargantini, L; Vanelli, M; Aguilar-Bryan, L; Stazi, M; Grasso, V; Colombo, C; Barbetti, F";s:9:"metadata7";s:25:"10.1007/s00125-011-2094-8";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:47;a:14:{s:9:"citazione";s:237:"Boesgaard, T.W., Pruhova, S., Andersson, E.A., Cinek, O., Obermannova, B., Lauenborg, J., et al. (2010). Further evidence that mutations in INS can be a rare cause of Maturity Onset Diabetes of the Young (MODY). BMC MEDICAL GENETICS, 42.";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_33392";s:6:"handle";s:10:"2108/44768";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:106:"Further evidence that mutations in INS can be a rare cause of Maturity Onset Diabetes of the Young (MODY).";s:9:"metadata6";s:174:"Boesgaard, TW; Pruhova, S; Andersson, EA; Cinek, O; Obermannova, B; Lauenborg, J; Damm, P; Bergholdt, R; Pociot, F; Pisinger, C; Barbetti, F; Lebl, J; Pedersen, O; Hansen, T.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:48;a:14:{s:9:"citazione";s:157:"Brufani C, C.P. (2010). Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy. PEDIATRIC DIABETES, 11, 47-54.";s:4:"data";s:4:"2010";s:2:"id";s:20:"PUBBLICAZIONE_104034";s:6:"handle";s:10:"2108/45069";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:101:"Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy";s:9:"metadata6";s:83:"Brufani C, Ciampalini P, Grossi A, Fiori R, Fintini D, Tozzi A, Cappa M, Barbetti F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:49;a:14:{s:9:"citazione";s:258:"Liu, M., Haataja, L., Wright, J., Wickramasinghe, D.N., Hua, Q., Phillips, N.F., et al. (2010). Mutant INS-gene induced diabetes of youth:proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport. PLOS ONE, 5, e13333.";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_32538";s:6:"handle";s:10:"2108/44767";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:140:"Mutant INS-gene induced diabetes of youth:proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport";s:9:"metadata6";s:108:"Liu, M; Haataja, L; Wright, J; Wickramasinghe, DN; Hua, Q-X; Phillips, NF; Barbetti, F; Weiss, MA; Arvan, P.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:50;a:14:{s:9:"citazione";s:246:"Prudente, S., Baratta, R., Andreozzi, F., Morini, E., Farina, M.G., Nigro, A., et al. (2010). TRIB3 R84 variant affects glucose homeostasis by alterino the interplay between insulin sensitività and insulin secretion. DIABETOLOGIA, 53, 1354-1361.";s:4:"data";s:4:"2010";s:2:"id";s:19:"PUBBLICAZIONE_33390";s:6:"handle";s:10:"2108/44769";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:123:"TRIB3 R84 variant affects glucose homeostasis by alterino the interplay between insulin sensitività and insulin secretion.";s:9:"metadata6";s:212:"Prudente, S; Baratta, R; Andreozzi, F; Morini, E; Farina, MG; Nigro, A; Copetti, M; Pellegrini, F; Succurro, E; Di Pietrantonio, L; Brufani, C; Barbetti, F; Dallapiccola, B; Sesti, G; Trischitta, V; Frittitta, L.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:51;a:14:{s:9:"citazione";s:318:"Barbetti, F., Cobo-Vuilleumier, N., Dionisi-Vici, C., Toni, S., Ciampalini, P., Massa, O., et al. (2009). Opposite clinical phenotypes of “glucokinase disease”: description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene. MOLECULAR ENDOCRINOLOGY, 23, 1983-1989.";s:4:"data";s:4:"2009";s:2:"id";s:19:"PUBBLICAZIONE_33399";s:6:"handle";s:10:"2108/44772";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:172:"Opposite clinical phenotypes of “glucokinase disease”: description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene.";s:9:"metadata6";s:233:"Barbetti, F; Cobo-Vuilleumier, N; Dionisi-Vici, C; Toni, S; Ciampalini, P; Massa, O; Rodriguez-Bada, P; Colombo, C; Lenzi, L; Garcia-Gimeno, MA; Bermudez, F; de Fonseca, FR; Banin, P; Aledo, JC; Baixeras, E; Sanz, P; Cuesta-Munoz, A.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:52;a:14:{s:9:"citazione";s:158:"Bonfanti R, C.C. (2009). Insulin gene mutations as cause of diabetes in children negative for five type 1 diabetes autoantibodies. DIABETES CARE, 32, 123-125.";s:4:"data";s:4:"2009";s:2:"id";s:20:"PUBBLICAZIONE_104013";s:6:"handle";s:10:"2108/44931";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:104:"Insulin gene mutations as cause of diabetes in children negative for five type 1 diabetes autoantibodies";s:9:"metadata6";s:100:"Bonfanti R, Colombo C, Nocerino V, Massa O, Iafusco D, Viscardi M, Chiumello G, Meschi F, Barbetti F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:53;a:14:{s:9:"citazione";s:191:"Brufani C, T.A. (2009). Sexual dimorphism of body composition and insulin sensitivity across pubertal development in obese Caucasian subjects. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 160, 769-775.";s:4:"data";s:4:"2009";s:2:"id";s:20:"PUBBLICAZIONE_104032";s:6:"handle";s:10:"2108/44930";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore BIO/12";s:9:"metadata4";N;s:9:"metadata5";s:117:"Sexual dimorphism of body composition and insulin sensitivity across pubertal development in obese Caucasian subjects";s:9:"metadata6";s:125:"Brufani C, Tozzi A, Fintini D, Ciampalini P, Grossi A, Fiori R, Kiepe D, Manco M, Schiaffini R, Porzio O, Cappa M, Barbetti F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:54;a:14:{s:9:"citazione";s:273:"Brufani, C., Grossi, A., Fintini, D., Tozzi, A., Nocerino, V., Patera, P.I., et al. (2009). Obese children with low birth weight demonstrate impaired beta-cell function during oral glucose tolerance test. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 94, 4448-4452.";s:4:"data";s:4:"2009";s:2:"id";s:19:"PUBBLICAZIONE_33405";s:6:"handle";s:10:"2108/44771";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:111:"Obese children with low birth weight demonstrate impaired beta-cell function during oral glucose tolerance test";s:9:"metadata6";s:116:"Brufani, C; Grossi, A; Fintini, D; Tozzi, A; Nocerino, V; Patera, PI; Ubertini, G; Porzio, O; Barbetti, F; Cappa, M.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:55;a:14:{s:9:"citazione";s:257:"Delvecchio M., Z.C. (2009). Sulfonylurea treatment in a girl with neonatal diabetes (KCNJ11 R201H) and celiac disease: Impact of low compliance to the gluten free diet. DIABETES RESEARCH AND CLINICAL PRACTICE, 84(3), 332-334 [10.1016/j.diabres.2009.02.024].";s:4:"data";s:4:"2009";s:2:"id";s:19:"PUBBLICAZIONE_13984";s:6:"handle";s:10:"2108/44817";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:139:"Sulfonylurea treatment in a girl with neonatal diabetes (KCNJ11 R201H) and celiac disease: Impact of low compliance to the gluten free diet";s:9:"metadata6";s:81:"Delvecchio M., Zecchino C., Faienza M.F., Acquafredda A., Barbetti F., Cavallo L.";s:9:"metadata7";s:29:"10.1016/j.diabres.2009.02.024";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:56;a:14:{s:9:"citazione";s:269:"Lorini, R., Klersy, C., D'Annunzio, G., Massa, O., Minuto, N., Iafusco, D., et al. (2009). Maturity-onset diabetes of the young in children with incidental hyperglycemia: a multicenter Italian study of 172 families. DIABETES CARE, 32(10), 1864-1866 [10.2337/dc08-2018].";s:4:"data";s:4:"2009";s:2:"id";s:19:"PUBBLICAZIONE_11132";s:6:"handle";s:10:"2108/44770";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:123:"Maturity-onset diabetes of the young in children with incidental hyperglycemia: a multicenter Italian study of 172 families";s:9:"metadata6";s:241:"Lorini, R; Klersy, C; D'Annunzio, G; Massa, O; Minuto, N; Iafusco, D; Bellanne-Chantelot, C; Frongia, A; Toni, S; Meschi, F; Cerutti, F; Barbetti, F; Manca Bitti, M; Italian Society of Pediatric Endocrinology and Diabetology (ISPED) Study, G";s:9:"metadata7";s:17:"10.2337/dc08-2018";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:57;a:14:{s:9:"citazione";s:224:"Nocerino, V., Colombo, C., Bonfanti, R., Iafusco, D., & Barbetti, F. (2009). Mutations in hIAPP and NEUROG3 genes are not a common cause of permanent neonatal/infancy/childhood onset diabetes. DIABETIC MEDICINE, 26, 660-661.";s:4:"data";s:4:"2009";s:2:"id";s:19:"PUBBLICAZIONE_33409";s:6:"handle";s:10:"2108/44773";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:115:"Mutations in hIAPP and NEUROG3 genes are not a common cause of permanent neonatal/infancy/childhood onset diabetes.";s:9:"metadata6";s:62:"Nocerino, V; Colombo, C; Bonfanti, R; Iafusco, D; Barbetti, F.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:58;a:14:{s:9:"citazione";s:109:"Baratta R, R.P. (2008). Role of the ENPP1 K121Q polymorphism on glucose homeostasis. DIABETES(57), 3360-3364.";s:4:"data";s:4:"2008";s:2:"id";s:20:"PUBBLICAZIONE_104012";s:6:"handle";s:10:"2108/45786";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:59:"Role of the ENPP1 K121Q polymorphism on glucose homeostasis";s:9:"metadata6";s:103:"Baratta R, Rossetti P, Prudente S, Barbetti F, Sudano D, Nigro A, Farina MG, Trischitta V, Frittitta L.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:59;a:14:{s:9:"citazione";s:261:"Colombo, C., PORZIO, O., Liu, M., Massa, O., Vasta, M., Salardi, S., et al. (2008). Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. THE JOURNAL OF CLINICAL INVESTIGATION, 118, 2148-2156 [10.1172/JCI33777].";s:4:"data";s:4:"2008";s:2:"id";s:20:"PUBBLICAZIONE_103933";s:6:"handle";s:10:"2108/44776";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:25:"Settore BIO/18 - Genetica";s:9:"metadata4";N;s:9:"metadata5";s:102:"Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus";s:9:"metadata6";s:219:"Colombo, C; PORZIO, O; Liu, M; Massa, O; Vasta, M; Salardi, S; Beccaria, L; Monciotti, C; Toni, S; Pedersen, O; Hansen, T; Federici, L; Pesavento, R; Cadario, F; FEDERICI, G; Ghirri, P; Arvan, P; Iafusco, D; BARBETTI, F";s:9:"metadata7";s:16:"10.1172/JCI33777";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:60;a:14:{s:9:"citazione";s:322:"Koster, J.C., Cadario, F., Peruzzi, C., Colombo, C., Nichols, C.G., & Barbetti, F. (2008). The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction that is improved with sulfonylurea therapy. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 93, 1054-1061 [10.1210/jc.2007-1826].";s:4:"data";s:4:"2008";s:2:"id";s:20:"PUBBLICAZIONE_103936";s:6:"handle";s:10:"2108/44775";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:139:"The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction that is improved with sulfonylurea therapy.";s:9:"metadata6";s:72:"Koster, JC; Cadario, F; Peruzzi, C; Colombo, C; Nichols, CG; Barbetti, F";s:9:"metadata7";s:20:"10.1210/jc.2007-1826";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:61;a:14:{s:9:"citazione";s:302:"Porzio, O., Massa, O., Cunsolo, V., Colombo, C., Malaponti, M., Bertuzzi, F., et al. (2007). Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes. Mutation in brief no. 982. Online. HUMAN MUTATION, 28(11), 1150-1150 [10.1002/humu.9511].";s:4:"data";s:7:"2007-11";s:2:"id";s:19:"PUBBLICAZIONE_88813";s:6:"handle";s:10:"2108/30425";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore BIO/12";s:9:"metadata4";N;s:9:"metadata5";s:153:"Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes. Mutation in brief no. 982. Online";s:9:"metadata6";s:276:"Porzio, O; Massa, O; Cunsolo, V; Colombo, C; Malaponti, M; Bertuzzi, F; Hansen, T; Johansen, A; Pedersen, O; Meschi, F; Terrinoni, A; Melino, G; Federici, M; Decarlo, N; Menicagli, M; Campani, D; Marchetti, P; Ferdaoussi, M; Froguel, P; Federici, G; Vaxillaire, M; Barbetti, F";s:9:"metadata7";s:17:"10.1002/humu.9511";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:62;a:14:{s:9:"citazione";s:81:"Barbetti, F. (2007). Diagnosis of neonatal and infancy-onset diabetes, 11, 83-93.";s:4:"data";s:4:"2007";s:2:"id";s:20:"PUBBLICAZIONE_103992";s:6:"handle";s:10:"2108/45335";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:48:"Diagnosis of neonatal and infancy-onset diabetes";s:9:"metadata6";s:12:"Barbetti, F.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:63;a:14:{s:9:"citazione";s:274:"Masia, R., Koster, J.C., Tumini, S., Chiarelli, F., Colombo, C., Nichols, C.G., et al. (2007). An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of DEND (Developmental Delay, Epilepsy, and Neonatal Diabetes). DIABETES, 56, 328-336.";s:4:"data";s:4:"2007";s:2:"id";s:20:"PUBBLICAZIONE_103937";s:6:"handle";s:10:"2108/44777";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:155:"An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of DEND (Developmental Delay, Epilepsy, and Neonatal Diabetes)";s:9:"metadata6";s:83:"Masia, R; Koster, JC; Tumini, S; Chiarelli, F; Colombo, C; Nichols, CG; Barbetti, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:64;a:14:{s:9:"citazione";s:207:"Sentinelli F, R.S. (2006). Search for genetic variants in the p66 Shc longevity gene by PCR-single strand conformational polymorphism in patients with early-onset cardiovascular disease. BMC GENETICS, 7, 14.";s:4:"data";s:4:"2006";s:2:"id";s:20:"PUBBLICAZIONE_103993";s:6:"handle";s:10:"2108/46229";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:34:"Settore MED/01 - Statistica Medica";s:9:"metadata4";N;s:9:"metadata5";s:159:"Search for genetic variants in the p66 Shc longevity gene by PCR-single strand conformational polymorphism in patients with early-onset cardiovascular disease.";s:9:"metadata6";s:88:"Sentinelli F, Romeo S, Barbetti F, Berni A, Filippi E, Fanelli M, Fallarino M, Baroni MG";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:65;a:14:{s:9:"citazione";s:172:"Shimomura K, G.C. (2006). Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects. DIABETES, 55, 1705-1712.";s:4:"data";s:4:"2006";s:2:"id";s:20:"PUBBLICAZIONE_103938";s:6:"handle";s:10:"2108/46228";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:120:"Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects";s:9:"metadata6";s:123:"Shimomura K, Girard CA, Proks P, Nazim J, Lippiat JD, Cerutti F, Lorini R, Ellard S, Hattersley AT, Barbetti F, Ashcroft FM";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:66;a:14:{s:9:"citazione";s:275:"Tonini G., B.C. (2006). Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene. DIABETOLOGIA, 49(9), 2210-2213 [10.1007/s00125-006-0329-x].";s:4:"data";s:4:"2006";s:2:"id";s:18:"PUBBLICAZIONE_2111";s:6:"handle";s:10:"2108/46227";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:190:"Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene";s:9:"metadata6";s:176:"Tonini G., Bizzarri C., Bonfanti R., Vanelli M., Cerutti F., Faleschini E., Meschi F., Prisco F., Ciacco E., Cappa M., Torelli C., Cauvin V., Tumini S., Iafusco D., Barbetti F.";s:9:"metadata7";s:25:"10.1007/s00125-006-0329-x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:67;a:14:{s:9:"citazione";s:256:"Colombo, C., Delvecchio, M., Zecchino, C., Faienza, M.f., Cavallo, L., & Barbetti, F. (2005). Transient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation. DIABETOLOGIA, 48(11), 2439-2441 [10.1007/s00125-005-1958-1].";s:4:"data";s:4:"2005";s:2:"id";s:20:"PUBBLICAZIONE_366822";s:6:"handle";s:11:"2108/228337";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:100:"Transient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation";s:9:"metadata6";s:76:"Colombo, C; Delvecchio, M; Zecchino, C; Faienza, Mf; Cavallo, L; Barbetti, F";s:9:"metadata7";s:25:"10.1007/s00125-005-1958-1";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:68;a:14:{s:9:"citazione";s:239:"Foti, D., Chiefari, E., Fedele, M., Iuliano, R., Brunetti, L., Paonessa, F., et al. (2005). Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. NATURE MEDICINE, 11(7), 765-773 [10.1038/nm1254].";s:4:"data";s:4:"2005";s:2:"id";s:20:"PUBBLICAZIONE_366821";s:6:"handle";s:11:"2108/228335";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:96:"Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice";s:9:"metadata6";s:145:"Foti, D; Chiefari, E; Fedele, M; Iuliano, R; Brunetti, L; Paonessa, F; Manfioletti, G; Barbetti, F; Brunetti, A; Croce, Cm; Fusco, A; Brunetti, A";s:9:"metadata7";s:14:"10.1038/nm1254";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:69;a:14:{s:9:"citazione";s:316:"Gloyn, A.l., Odili, S., Zelent, D., Buettger, C., Castleden, H., Steele, A.m., et al. (2005). Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. THE JOURNAL OF BIOLOGICAL CHEMISTRY, 280(14), 14105-14113 [10.1074/jbc.M413146200].";s:4:"data";s:4:"2005";s:2:"id";s:20:"PUBBLICAZIONE_366823";s:6:"handle";s:11:"2108/228339";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:137:"Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young";s:9:"metadata6";s:292:"Gloyn, Al; Odili, S; Zelent, D; Buettger, C; Castleden, Haj; Steele, Am; Stride, A; Shiota, C; Magnuson, Ma; Lorini, R; D'Annunzio, G; Stanley, Ca; Kwagh, J; Van Schaftingen, E; Veiga-Da-Cunha, M; Barbetti, F; Dunten, P; Han, Y; Grimsby, J; Taub, R; Ellard, S; Hattersley, At; Matschinsky, Fm";s:9:"metadata7";s:22:"10.1074/jbc.M413146200";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:70;a:14:{s:9:"citazione";s:134:"Massa O., I.D. (2005). KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. HUMAN MUTATION, 25(1), 22-27.";s:4:"data";s:4:"2005";s:2:"id";s:19:"PUBBLICAZIONE_17140";s:6:"handle";s:10:"2108/49208";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore BIO/12";s:9:"metadata4";N;s:9:"metadata5";s:80:"KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes";s:9:"metadata6";s:203:"Massa O., Iafusco D., D'Amato E., Gloyn A.L., Hattersley A.T., Pasquino B., Tonini G., Dammacco F., Zanette G., Meschi F., Porzio O., Bottazzo G., Crino A., Lorini R., Cerutti F., Vanelli M., Barbetti F.";s:9:"metadata7";s:18:"10.1002/humu.20124";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:71;a:14:{s:9:"citazione";s:262:"Bernassola, F., Federici, M., Corazzari, M., Terrinoni, A., Hribal, M.l., De Laurenzi, V., et al. (2002). Role of transglutaminase 2 in glucose tolerance: Knockout mice studies and a putative mutation in a MODY patient, 16(11), 1371-1378 [10.1096/fj.01-0689com].";s:4:"data";s:4:"2002";s:2:"id";s:18:"PUBBLICAZIONE_1865";s:6:"handle";s:10:"2108/50079";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore BIO/11";s:9:"metadata4";N;s:9:"metadata5";s:112:"Role of transglutaminase 2 in glucose tolerance: Knockout mice studies and a putative mutation in a MODY patient";s:9:"metadata6";s:165:"Bernassola, F; Federici, M; Corazzari, M; Terrinoni, A; Hribal, Ml; De Laurenzi, V; Ranalli, M; Massa, O; Sesti, G; Irwin Mclean, W; Citro, G; Barbetti, F; Melino, G";s:9:"metadata7";s:21:"10.1096/fj.01-0689com";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:72;a:14:{s:9:"citazione";s:269:"Christesen, H., Jacobsen, B.b., Odili, S., Buettger, C., Cuesta-Munoz, A., Hansen, T., et al. (2002). The second activating glucokinase mutation (A456V): Implications for glucose homeostasis and diabetes therapy. DIABETES, 51(4), 1240-1246 [10.2337/diabetes.51.4.1240].";s:4:"data";s:4:"2002";s:2:"id";s:20:"PUBBLICAZIONE_366828";s:6:"handle";s:11:"2108/228329";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:109:"The second activating glucokinase mutation (A456V): Implications for glucose homeostasis and diabetes therapy";s:9:"metadata6";s:159:"Christesen, Hbt; Jacobsen, Bb; Odili, S; Buettger, C; Cuesta-Munoz, A; Hansen, T; Brusgaard, K; Massa, O; Magnuson, Ma; Shiota, C; Matschinsky, Fm; Barbetti, F";s:9:"metadata7";s:26:"10.2337/diabetes.51.4.1240";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:73;a:14:{s:9:"citazione";s:212:"Iafusco, D., Stazi, M., Cotichini, R., Cotellessa, M., Martinucci, M., Mazzella, M., et al. (2002). Permanent diabetes mellitus in the first year of life. DIABETOLOGIA, 45(6), 798-804 [10.1007/s00125-002-0837-2].";s:4:"data";s:4:"2002";s:2:"id";s:20:"PUBBLICAZIONE_366827";s:6:"handle";s:11:"2108/228331";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:53:"Permanent diabetes mellitus in the first year of life";s:9:"metadata6";s:142:"Iafusco, D; Stazi, M; Cotichini, R; Cotellessa, M; Martinucci, M; Mazzella, M; Cherubini, V; Barbetti, F; Martinetti, M; Cerutti, F; Prisco, F";s:9:"metadata7";s:25:"10.1007/s00125-002-0837-2";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:74;a:14:{s:9:"citazione";s:327:"Montoli, A., Colussi, G., Massa, O., Caccia, R., Rizzoni, G., Civati, G., et al. (2002). Renal cysts and diabetes syndrome linked to mutations of the hepatocyte nuclear factor-1β gene: Description of a new family with associated liver involvement. AMERICAN JOURNAL OF KIDNEY DISEASES, 40(2), 397-402 [10.1053/ajkd.2002.34538].";s:4:"data";s:4:"2002";s:2:"id";s:20:"PUBBLICAZIONE_366826";s:6:"handle";s:11:"2108/228327";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:158:"Renal cysts and diabetes syndrome linked to mutations of the hepatocyte nuclear factor-1β gene: Description of a new family with associated liver involvement";s:9:"metadata6";s:79:"Montoli, A; Colussi, G; Massa, O; Caccia, R; Rizzoni, G; Civati, G; Barbetti, F";s:9:"metadata7";s:23:"10.1053/ajkd.2002.34538";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:75;a:14:{s:9:"citazione";s:243:"Stride, A., Vaxillaire, M., Tuomi, T., Barbetti, F., Njolstad, P.r., Hansen, T., et al. (2002). The genetic abnormality in the beta cell determines the response to an oral glucose load. DIABETOLOGIA, 45(3), 427-435 [10.1007/s00125-001-0770-9].";s:4:"data";s:4:"2002";s:2:"id";s:20:"PUBBLICAZIONE_367454";s:6:"handle";s:11:"2108/228333";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:88:"The genetic abnormality in the beta cell determines the response to an oral glucose load";s:9:"metadata6";s:165:"Stride, A; Vaxillaire, M; Tuomi, T; Barbetti, F; Njolstad, Pr; Hansen, T; Costa, A; Conget, I; Pedersen, O; Sovik, O; Lorini, R; Groop, L; Froguel, P; Hattersley, At";s:9:"metadata7";s:25:"10.1007/s00125-001-0770-9";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:76;a:14:{s:9:"citazione";s:282:"Massa, O., Meschi, F., Cuesta-Munoz, A., Caumo, A., Cerutti, F., Toni, S., et al. (2001). High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. DIABETOLOGIA, 44(7), 898-905.";s:4:"data";s:4:"2001";s:2:"id";s:20:"PUBBLICAZIONE_367456";s:6:"handle";s:11:"2108/228325";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:161:"High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI";s:9:"metadata6";s:159:"Massa, O; Meschi, F; Cuesta-Munoz, A; Caumo, A; Cerutti, F; Toni, S; Cherubini, V; Guazzarotti, L; Sulli, N; Matschinsky, F; Lorini, R; Iafusco, D; Barbetti, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:77;a:14:{s:9:"citazione";s:249:"Njolstad, P.r., Sovik, O., Cuesta-Munoz, A., Bjorkhaug, L., Massa, O., Barbetti, F., et al. (2001). Neonatal diabetes mellitus due to complete glucokinase deficiency. NEW ENGLAND JOURNAL OF MEDICINE, 344(21), 1588-1592 [10.1056/NEJM200105243442104].";s:4:"data";s:4:"2001";s:2:"id";s:20:"PUBBLICAZIONE_366829";s:6:"handle";s:11:"2108/228322";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:65:"Neonatal diabetes mellitus due to complete glucokinase deficiency";s:9:"metadata6";s:152:"Njolstad, Pr; Sovik, O; Cuesta-Munoz, A; Bjorkhaug, L; Massa, O; Barbetti, F; Undlien, De; Shiota, C; Magnuson, Ma; Molven, A; Matschinsky, Fm; Bell, Gi";s:9:"metadata7";s:27:"10.1056/NEJM200105243442104";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:78;a:14:{s:9:"citazione";s:367:"Hansen, L., Urioste, S., Petersen, H.v., Jensen, J.n., Eiberg, H., Barbetti, F., et al. (2000). Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in caucasians. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 85(3), 1323-1326 [10.1210/jc.85.3.1323].";s:4:"data";s:4:"2000";s:2:"id";s:20:"PUBBLICAZIONE_367457";s:6:"handle";s:11:"2108/228317";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:175:"Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in caucasians";s:9:"metadata6";s:105:"Hansen, L; Urioste, S; Petersen, Hv; Jensen, Jn; Eiberg, H; Barbetti, F; Serup, P; Hansen, T; Pedersen, O";s:9:"metadata7";s:20:"10.1210/jc.85.3.1323";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:79;a:14:{s:9:"citazione";s:237:"Prisco, F., Iafusco, D., Franzese, A., Sulli, N., & Barbetti, F. (2000). MODY 2 presenting as neonatal hyperglycaemia: A need to reshape the definition of 'neonatal diabetes'? [2]. DIABETOLOGIA, 43(10), 1331-1332 [10.1007/s001250051531].";s:4:"data";s:4:"2000";s:2:"id";s:20:"PUBBLICAZIONE_367458";s:6:"handle";s:11:"2108/228320";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:106:"MODY 2 presenting as neonatal hyperglycaemia: A need to reshape the definition of 'neonatal diabetes'? [2]";s:9:"metadata6";s:57:"Prisco, F; Iafusco, D; Franzese, A; Sulli, N; Barbetti, F";s:9:"metadata7";s:21:"10.1007/s001250051531";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:80;a:14:{s:9:"citazione";s:515:"Hansen, L., Fjordvang, H., Rasmussen, S.k., Vestergaard, H., Echwald, S.m., Hansen, T., et al. (1999). Mutational analysis of the coding regions of the genes encoding protein kinase B-α and -β, phosphoinositide-dependent protein kinase-1, phosphatase targeting to glycogen, protein phosphatase inhibitor-1, and glycogenin: Lessons from a search for genetic variability of the insulin-stimulated glycogen synthesis pathway of skeletal muscle in NIDDM patients. DIABETES, 48(2), 403-407 [10.2337/diabetes.48.2.403].";s:4:"data";s:4:"1999";s:2:"id";s:20:"PUBBLICAZIONE_367460";s:6:"handle";s:11:"2108/228313";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:255:"Mutational analysis of the coding regions of the genes encoding protein kinase B-α and -β, phosphoinositide-dependent protein kinase-1, phosphatase targeting to glycogen, protein phosphatase inhibitor-1, and glycogenin: Lessons from a search for gene...";s:9:"metadata6";s:143:"Hansen, L; Fjordvang, H; Rasmussen, Sk; Vestergaard, H; Echwald, Sm; Hansen, T; Alessi, D; Shenolikar, S; Saltiel, Ar; Barbetti, F; Pedersen, O";s:9:"metadata7";s:25:"10.2337/diabetes.48.2.403";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:81;a:14:{s:9:"citazione";s:175:"Maggi, D., Barbetti, F., & Cordera, R. (1999). Role of proline 193 in the insulin receptor post-translational processing. DIABETOLOGIA, 42(4), 435-442 [10.1007/s001250051176].";s:4:"data";s:4:"1999";s:2:"id";s:20:"PUBBLICAZIONE_367459";s:6:"handle";s:11:"2108/228315";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:73:"Role of proline 193 in the insulin receptor post-translational processing";s:9:"metadata6";s:33:"Maggi, D; Barbetti, F; Cordera, R";s:9:"metadata7";s:21:"10.1007/s001250051176";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:82;a:14:{s:9:"citazione";s:235:"D'Adamo, M., Buongiorno, A., Maroccia, E., Leonetti, F., Barbetti, F., Giaccari, A., et al. (1998). Increased OB gene expression leads to elevated plasma leptin concetrations in patients with chronic primary hyperinsulinemia. DIABETES.";s:4:"data";s:4:"1998";s:2:"id";s:20:"PUBBLICAZIONE_367491";s:6:"handle";s:11:"2108/228311";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:124:"Increased OB gene expression leads to elevated plasma leptin concetrations in patients with chronic primary hyperinsulinemia";s:9:"metadata6";s:118:"D'Adamo, M; Buongiorno, A; Maroccia, E; Leonetti, F; Barbetti, F; Giaccari, A; Zorretta, D; Tamburrano, G; Sbraccia, P";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:83;a:14:{s:9:"citazione";s:304:"Guazzini, B., Gaffi, D., Mainieri, D., Multari, G., Cordera, R., Bertolini, S., et al. (1998). Three novel missense mutations in the glucokinase gene (G80S; E221K; G227C) in Italian subjects with maturity-onset diabetes of the young (MODY). Mutations in brief no. 162. Online. HUMAN MUTATION, 12(2), 136.";s:4:"data";s:4:"1998";s:2:"id";s:20:"PUBBLICAZIONE_367493";s:6:"handle";s:11:"2108/228309";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:180:"Three novel missense mutations in the glucokinase gene (G80S; E221K; G227C) in Italian subjects with maturity-onset diabetes of the young (MODY). Mutations in brief no. 162. Online";s:9:"metadata6";s:106:"Guazzini, B; Gaffi, D; Mainieri, D; Multari, G; Cordera, R; Bertolini, S; Pozza, G; Meschi, F; Barbetti, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:84;a:14:{s:9:"citazione";s:184:"Barbetti, F. (1996). Pathophysiology of non-insulin-dependent diabetes and the search for candidate genes: Dangerous liaisons?. ACTA DIABETOLOGICA, 33(4), 257-262 [10.1007/BF00571560].";s:4:"data";s:4:"1996";s:2:"id";s:20:"PUBBLICAZIONE_367495";s:6:"handle";s:11:"2108/228303";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:105:"Pathophysiology of non-insulin-dependent diabetes and the search for candidate genes: Dangerous liaisons?";s:9:"metadata6";s:11:"Barbetti, F";s:9:"metadata7";s:18:"10.1007/BF00571560";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:85;a:14:{s:9:"citazione";s:287:"Barbetti, F., Rocchi, M., Bossolasco, M., Cordera, R., Sbraccia, P., Finelli, P., et al. (1996). The human skeletal muscle glycogenin gene: cDNA, tissue expression, and chromosomal localization. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 220(1), 72-77 [10.1006/bbrc.1996.0359].";s:4:"data";s:4:"1996";s:2:"id";s:20:"PUBBLICAZIONE_367494";s:6:"handle";s:11:"2108/228307";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:96:"The human skeletal muscle glycogenin gene: cDNA, tissue expression, and chromosomal localization";s:9:"metadata6";s:88:"Barbetti, F; Rocchi, M; Bossolasco, M; Cordera, R; Sbraccia, P; Finelli, P; Consalez, Gg";s:9:"metadata7";s:22:"10.1006/bbrc.1996.0359";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:86;a:14:{s:9:"citazione";s:252:"Terregino, C., Cardona, F., Barbetti, F., Antonozzi, I., & Carducci, C. (1996). Clinical and molecular evaluation of Italian patients affected by Pelizaeus-Merzbacher disease. JOURNAL OF INHERITED METABOLIC DISEASE, 19(2), 197-200 [10.1007/BF01799428].";s:4:"data";s:4:"1996";s:2:"id";s:20:"PUBBLICAZIONE_367497";s:6:"handle";s:11:"2108/228305";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:43:"Settore MED/39 - Neuropsichiatria Infantile";s:9:"metadata4";N;s:9:"metadata5";s:94:"Clinical and molecular evaluation of Italian patients affected by Pelizaeus-Merzbacher disease";s:9:"metadata6";s:64:"Terregino, C; Cardona, F; Barbetti, F; Antonozzi, I; Carducci, C";s:9:"metadata7";s:18:"10.1007/BF01799428";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:87;a:14:{s:9:"citazione";s:269:"Wertheimer, E., Barbetti, F., Muggeo, M., Roth, J., & Taylor, S.i. (1994). Two mutations in a conserved structural motif in the insulin receptor inhibit normal folding and intracellular transport of the receptor. THE JOURNAL OF BIOLOGICAL CHEMISTRY, 269(10), 7587-7592.";s:4:"data";s:4:"1994";s:2:"id";s:20:"PUBBLICAZIONE_367500";s:6:"handle";s:11:"2108/228301";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:136:"Two mutations in a conserved structural motif in the insulin receptor inhibit normal folding and intracellular transport of the receptor";s:9:"metadata6";s:58:"Wertheimer, E; Barbetti, F; Muggeo, M; Roth, J; Taylor, Si";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:88;a:14:{s:9:"citazione";s:298:"Wertheimer, E., Litvin, Y., Ebstein, R.p., Bennett, E.r., Barbetti, F., Accili, D., et al. (1994). Deletion of exon 3 of the insulin receptor gene in a kindred with a familial form of insulin resistance. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 78(5), 1153-1158 [10.1210/jc.78.5.1153].";s:4:"data";s:4:"1994";s:2:"id";s:20:"PUBBLICAZIONE_367498";s:6:"handle";s:11:"2108/228297";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:103:"Deletion of exon 3 of the insulin receptor gene in a kindred with a familial form of insulin resistance";s:9:"metadata6";s:86:"Wertheimer, E; Litvin, Y; Ebstein, Rp; Bennett, Er; Barbetti, F; Accili, D; Taylor, Si";s:9:"metadata7";s:20:"10.1210/jc.78.5.1153";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:89;a:14:{s:9:"citazione";s:285:"Carrera, P., Cordera, R., Ferrari, M., Cremonesi, L., Taramelli, R., Andraghetti, G., et al. (1993). Substitution of leu for pro-193 in the insulin receptor in a patient with a genetic form of severe insulin resistance. HUMAN MOLECULAR GENETICS, 2(9), 1437-1441 [10.1093/hmg/2.9.1437].";s:4:"data";s:4:"1993";s:2:"id";s:20:"PUBBLICAZIONE_367502";s:6:"handle";s:11:"2108/228260";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:117:"Substitution of leu for pro-193 in the insulin receptor in a patient with a genetic form of severe insulin resistance";s:9:"metadata6";s:147:"Carrera, P; Cordera, R; Ferrari, M; Cremonesi, L; Taramelli, R; Andraghetti, G; Carducci, C; Dozio, N; Pozza, G; Taylor, S; Micossi, P; Barbetti, F";s:9:"metadata7";s:20:"10.1093/hmg/2.9.1437";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:90;a:14:{s:9:"citazione";s:307:"Accili, D., Barbetti, F., Cama, A., Kadowaki, H., Kadowaki, T., Imano, E., et al. (1992). Mutations in the insulin receptor gene in patients with genetic syndromes of insulin resistance and acanthosis nigricans. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 98(6 SUPPL.), 77S-81S-S81 [10.1111/1523-1747.ep12462281].";s:4:"data";s:4:"1992";s:2:"id";s:20:"PUBBLICAZIONE_367504";s:6:"handle";s:11:"2108/228295";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:120:"Mutations in the insulin receptor gene in patients with genetic syndromes of insulin resistance and acanthosis nigricans";s:9:"metadata6";s:97:"Accili, D; Barbetti, F; Cama, A; Kadowaki, H; Kadowaki, T; Imano, E; Levy-Toledano, R; Taylor, Si";s:9:"metadata7";s:28:"10.1111/1523-1747.ep12462281";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:91;a:14:{s:9:"citazione";s:246:"Accili, D., Cama, A., Barbetti, F., Kadowaki, H., Kadowaki, T., & Taylor, S.i. (1992). Insulin resistance due to mutations of the insulin receptor gene: An overview. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 15(11), 857-864 [10.1007/BF03348820].";s:4:"data";s:4:"1992";s:2:"id";s:20:"PUBBLICAZIONE_367503";s:6:"handle";s:11:"2108/228281";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:77:"Insulin resistance due to mutations of the insulin receptor gene: An overview";s:9:"metadata6";s:69:"Accili, D; Cama, A; Barbetti, F; Kadowaki, H; Kadowaki, T; Taylor, Si";s:9:"metadata7";s:18:"10.1007/BF03348820";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:92;a:14:{s:9:"citazione";s:235:"Barbetti, F., Gejman, P.v., Taylor, S.i., Raben, N., Cama, A., Bonora, E., et al. (1992). Detection of mutations in insulin receptor gene by denaturing gradient gel electrophoresis. DIABETES, 41(4), 408-415 [10.2337/diabetes.41.4.408].";s:4:"data";s:4:"1992";s:2:"id";s:20:"PUBBLICAZIONE_367506";s:6:"handle";s:11:"2108/228279";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:90:"Detection of mutations in insulin receptor gene by denaturing gradient gel electrophoresis";s:9:"metadata6";s:108:"Barbetti, F; Gejman, Pv; Taylor, Si; Raben, N; Cama, A; Bonora, E; Pizzo, P; Moghetti, P; Muggeo, M; Roth, J";s:9:"metadata7";s:25:"10.2337/diabetes.41.4.408";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:93;a:14:{s:9:"citazione";s:181:"Taylor, S., Cama, A., Accili, D., Barbetti, F., Quon, M., Sierra, M., et al. (1992). MUTATIONS IN THE INSULIN-RECEPTOR GENE. ENDOCRINE REVIEWS, 13(3), 566-595 [10.1210/er.13.3.566].";s:4:"data";s:4:"1992";s:2:"id";s:20:"PUBBLICAZIONE_367507";s:6:"handle";s:11:"2108/228283";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:38:"MUTATIONS IN THE INSULIN-RECEPTOR GENE";s:9:"metadata6";s:154:"Taylor, S; Cama, A; Accili, D; Barbetti, F; Quon, M; Sierra, M; Suzuki, Y; Koller, E; Levytoledano, R; Wertheimer, E; Moncada, V; Kadowaki, H; Kadowaki, T";s:9:"metadata7";s:19:"10.1210/er.13.3.566";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:94;a:14:{s:9:"citazione";s:269:"Raben, N., Barbetti, F., Cama, A., Lesniak, M.a., Lillioja, S., Zimmet, P., et al. (1991). Normal coding sequence of insulin gene in Pima Indians and Nauruans, two groups with highest prevalence of type II diabetes. DIABETES, 40(1), 118-122 [10.2337/diabetes.40.1.118].";s:4:"data";s:4:"1991";s:2:"id";s:20:"PUBBLICAZIONE_367511";s:6:"handle";s:11:"2108/228275";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:123:"Normal coding sequence of insulin gene in Pima Indians and Nauruans, two groups with highest prevalence of type II diabetes";s:9:"metadata6";s:105:"Raben, N; Barbetti, F; Cama, A; Lesniak, Ma; Lillioja, S; Zimmet, P; Serjeantson, Sw; Taylor, Si; Roth, J";s:9:"metadata7";s:25:"10.2337/diabetes.40.1.118";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:95;a:14:{s:9:"citazione";s:282:"Taylor, S.i., Cama, A., Accili, D., Barbetti, F., Imano, E., Kadowaki, H., et al. (1991). Genetic basis of endocrine disease 1 molecular genetics of insulin resistant diabetes mellitus. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 73(6), 1158-1163 [10.1210/jcem-73-6-1158].";s:4:"data";s:4:"1991";s:2:"id";s:20:"PUBBLICAZIONE_367508";s:6:"handle";s:11:"2108/228273";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:94:"Genetic basis of endocrine disease 1 molecular genetics of insulin resistant diabetes mellitus";s:9:"metadata6";s:79:"Taylor, Si; Cama, A; Accili, D; Barbetti, F; Imano, E; Kadowaki, H; Kadowaki, T";s:9:"metadata7";s:22:"10.1210/jcem-73-6-1158";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:96;a:14:{s:9:"citazione";s:275:"Barbetti, F., Crescenti, C., Negri, M., Leonetti, F., Grossi, A., & Tamburrano, G. (1990). Growth hormone does not inhibit its own secretion during prolonged hypoglycemia in man. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 70(5), 1371-1374 [10.1210/jcem-70-5-1371].";s:4:"data";s:4:"1990";s:2:"id";s:20:"PUBBLICAZIONE_367512";s:6:"handle";s:11:"2108/228271";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:86:"Growth hormone does not inhibit its own secretion during prolonged hypoglycemia in man";s:9:"metadata6";s:74:"Barbetti, F; Crescenti, C; Negri, M; Leonetti, F; Grossi, A; Tamburrano, G";s:9:"metadata7";s:22:"10.1210/jcem-70-5-1371";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:97;a:14:{s:9:"citazione";s:460:"Barbetti, F., Raben, N., Kadowaki, T., Cama, A., Accili, D., Gabbay, K.h., et al. (1990). Two unrelated patients with familial hyperproinsulinemia due to a mutation substituting histidine for arginine at position 65 in the proinsulin molecule: Identification of the mutation by direct sequencing of genomic deoxyribonucleic acid amplified by polymerase chain reaction. THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 71(1), 164-169 [10.1210/jcem-71-1-164].";s:4:"data";s:4:"1990";s:2:"id";s:20:"PUBBLICAZIONE_367513";s:6:"handle";s:11:"2108/228269";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:255:"Two unrelated patients with familial hyperproinsulinemia due to a mutation substituting histidine for arginine at position 65 in the proinsulin molecule: Identification of the mutation by direct sequencing of genomic deoxyribonucleic acid amplified by ...";s:9:"metadata6";s:101:"Barbetti, F; Raben, N; Kadowaki, T; Cama, A; Accili, D; Gabbay, Kh; Merenich, Ja; Taylor, Si; Roth, J";s:9:"metadata7";s:21:"10.1210/jcem-71-1-164";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:98;a:14:{s:9:"citazione";s:243:"Taylor, S.i., Barbetti, F., Accili, D., Roth, J., & Gorden, P. (1989). Syndromes of autoimmunity and hypoglycemia. Autoantibodies directed against insulin and its receptor. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 18(1), 123-143.";s:4:"data";s:4:"1989";s:2:"id";s:20:"PUBBLICAZIONE_367514";s:6:"handle";s:11:"2108/228267";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:100:"Syndromes of autoimmunity and hypoglycemia. Autoantibodies directed against insulin and its receptor";s:9:"metadata6";s:54:"Taylor, Si; Barbetti, F; Accili, D; Roth, J; Gorden, P";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:99;a:14:{s:9:"citazione";s:199:"Vernia, P., Caprilli, R., Latella, G., Barbetti, F., Magliocca, F.m., & Cittadini, M. (1988). Fecal Lactate and Ulcerative Colitis. GASTROENTEROLOGY, 95(6), 1564-1568 [10.1016/S0016-5085(88)80078-7].";s:4:"data";s:4:"1988";s:2:"id";s:20:"PUBBLICAZIONE_367517";s:6:"handle";s:11:"2108/228265";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:34:"Settore MED/12 - Gastroenterologia";s:9:"metadata4";N;s:9:"metadata5";s:36:"Fecal Lactate and Ulcerative Colitis";s:9:"metadata6";s:76:"Vernia, P; Caprilli, R; Latella, G; Barbetti, F; Magliocca, Fm; Cittadini, M";s:9:"metadata7";s:29:"10.1016/S0016-5085(88)80078-7";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:100;a:14:{s:9:"citazione";s:237:"Annibale, B., Delle Fave, G., Barbetti, F., De Magistris, L., Puoti, M., Giordano, E., et al. (1987). Dose-response effect of somatostatin-14 on human basal pancreatic hormones. PANCREAS, 2(5), 551-556 [10.1097/00006676-198709000-00010].";s:4:"data";s:4:"1987";s:2:"id";s:20:"PUBBLICAZIONE_367519";s:6:"handle";s:11:"2108/228263";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:74:"Dose-response effect of somatostatin-14 on human basal pancreatic hormones";s:9:"metadata6";s:107:"Annibale, B; Delle Fave, G; Barbetti, F; De Magistris, L; Puoti, M; Giordano, E; Leonetti, F; Tamburrano, G";s:9:"metadata7";s:32:"10.1097/00006676-198709000-00010";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:101;a:14:{s:9:"citazione";s:254:"Salabe, G.B., Tomei, E., Barbetti, F., Gentile, F., Fusconi, E., & Grossi, A. (1987). High incidence of empty sella in long-term hypothyroidism|Elevata frequenza di sella vuota negli ipotiroidismi di lunga durata. MINERVA ENDOCRINOLOGICA, 12(4), 273-280.";s:4:"data";s:4:"1987";s:2:"id";s:20:"PUBBLICAZIONE_367518";s:6:"handle";s:11:"2108/237622";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:126:"High incidence of empty sella in long-term hypothyroidism|Elevata frequenza di sella vuota negli ipotiroidismi di lunga durata";s:9:"metadata6";s:68:"Salabe, GB; Tomei, E; Barbetti, F; Gentile, F; Fusconi, E; Grossi, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:102;a:14:{s:9:"citazione";s:256:"Maldonato, A., Cama, A., Marani, F., Lucisano, A., Maniccia, E., Luciani, G., et al. (1985). Amniotic membrane chambers for pancreatic islet transplantation: The diffusion patterns of glucose and insulin. TRANSPLANTATION PROCEEDINGS, 17(SUPPL. 2), 146-147.";s:4:"data";s:4:"1985";s:2:"id";s:20:"PUBBLICAZIONE_367520";s:6:"handle";s:11:"2108/237620";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:110:"Amniotic membrane chambers for pancreatic islet transplantation: The diffusion patterns of glucose and insulin";s:9:"metadata6";s:121:"Maldonato, A; Cama, A; Marani, F; Lucisano, A; Maniccia, E; Luciani, G; Cascella, V; Barbetti, F; Falucca, F; Andreani, D";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:103;a:14:{s:9:"citazione";s:203:"Fallucca, F., Barbetti, F., Maldonato, A., Spallone, V., Giangrande, L., & Gambardella, S. (1982). Effects of somatostatin on established induced ketosis. HORMONE AND METABOLIC RESEARCH, 14(10), 512-515.";s:4:"data";s:7:"1982-10";s:2:"id";s:20:"PUBBLICAZIONE_199988";s:6:"handle";s:10:"2108/95218";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:54:"Effects of somatostatin on established induced ketosis";s:9:"metadata6";s:82:"Fallucca, F; Barbetti, F; Maldonato, A; Spallone, V; Giangrande, L; Gambardella, S";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:104;a:14:{s:9:"citazione";s:259:"Fallucca, F., Mirabella, C., Tamburrano, G., Gambardella, S., Aufieri, G., Barbetti, F., et al. (1979). Effects of somatostatin on insulin and glucagon in patients with insulinoma. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2(3), 257-260 [10.1007/BF03350412].";s:4:"data";s:4:"1979";s:2:"id";s:20:"PUBBLICAZIONE_367521";s:6:"handle";s:11:"2108/237618";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:75:"Effects of somatostatin on insulin and glucagon in patients with insulinoma";s:9:"metadata6";s:94:"Fallucca, F; Mirabella, C; Tamburrano, G; Gambardella, S; Aufieri, G; Barbetti, F; Andreani, D";s:9:"metadata7";s:18:"10.1007/BF03350412";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}}" } ["meta_keywords"]=> array(1) { [0]=> string(1) "," } ["reserved"]=> array(1) { [0]=> string(1) "0" } ["auth_ip"]=> array(1) { [0]=> string(1) "0" } } ["_fieldBoosts":protected]=> array(6) { ["content_id"]=> bool(false) ["content_title"]=> bool(false) ["description"]=> bool(false) ["meta_keywords"]=> bool(false) ["reserved"]=> bool(false) ["auth_ip"]=> bool(false) } } }